(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Exhibit Number | Description | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
COUCHBASE, INC. | |||||||||||
/s/ GREG HENRY | |||||||||||
By: | Greg Henry | ||||||||||
Title: | Chief Financial Officer (Principal Financial Officer) | ||||||||||
Q3 FY2025 Outlook | FY2025 Outlook | |||||||||||||
Total Revenue | $50.3-51.1 million | $205.1-209.1 million | ||||||||||||
Total ARR | $218.5-221.5 million | $235.5-240.5 million | ||||||||||||
Non-GAAP Operating Loss | $5.5-4.5 million | $24.5-19.5 million |
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
License | $ | 5,242 | $ | 4,798 | $ | 12,101 | $ | 9,741 | |||||||||||||||
Support and other | 44,051 | 36,156 | 86,230 | 69,755 | |||||||||||||||||||
Total subscription revenue | 49,293 | 40,954 | 98,331 | 79,496 | |||||||||||||||||||
Services | 2,296 | 2,185 | 4,585 | 4,639 | |||||||||||||||||||
Total revenue | 51,589 | 43,139 | 102,916 | 84,135 | |||||||||||||||||||
Cost of revenue: | |||||||||||||||||||||||
Subscription(1) | 4,455 | 3,845 | 8,412 | 7,518 | |||||||||||||||||||
Services(1) | 2,008 | 2,064 | 3,733 | 4,313 | |||||||||||||||||||
Total cost of revenue | 6,463 | 5,909 | 12,145 | 11,831 | |||||||||||||||||||
Gross profit | 45,126 | 37,230 | 90,771 | 72,304 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research and development(1) | 17,370 | 16,292 | 35,217 | 31,675 | |||||||||||||||||||
Sales and marketing(1) | 36,168 | 32,348 | 73,923 | 64,901 | |||||||||||||||||||
General and administrative(1) | 12,636 | 10,459 | 25,219 | 20,084 | |||||||||||||||||||
Restructuring(1) | — | — | — | 46 | |||||||||||||||||||
Total operating expenses | 66,174 | 59,099 | 134,359 | 116,706 | |||||||||||||||||||
Loss from operations | (21,048) | (21,869) | (43,588) | (44,402) | |||||||||||||||||||
Interest expense | (29) | (18) | (29) | (43) | |||||||||||||||||||
Other income, net | 1,741 | 1,255 | 3,272 | 2,688 | |||||||||||||||||||
Loss before income taxes | (19,336) | (20,632) | (40,345) | (41,757) | |||||||||||||||||||
Provision for income taxes | 559 | 19 | 545 | 769 | |||||||||||||||||||
Net loss | $ | (19,895) | $ | (20,651) | $ | (40,890) | $ | (42,526) | |||||||||||||||
Net loss per share, basic and diluted | $ | (0.39) | $ | (0.44) | $ | (0.81) | $ | (0.92) | |||||||||||||||
Weighted-average shares used in computing net loss per share, basic and diluted | 50,822 | 46,714 | 50,311 | 46,285 |
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Cost of revenue—subscription | $ | 301 | $ | 236 | $ | 567 | $ | 429 | |||||||||||||||
Cost of revenue—services | 109 | 149 | 250 | 294 | |||||||||||||||||||
Research and development | 4,214 | 3,614 | 8,207 | 6,382 | |||||||||||||||||||
Sales and marketing | 6,162 | 4,032 | 11,385 | 7,273 | |||||||||||||||||||
General and administrative | 5,370 | 4,086 | 10,374 | 7,014 | |||||||||||||||||||
Restructuring | — | — | — | 1 | |||||||||||||||||||
Total stock-based compensation expense | $ | 16,156 | $ | 12,117 | $ | 30,783 | $ | 21,393 |
As of July 31, 2024 | As of January 31, 2024 | ||||||||||
Assets | |||||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | 62,607 | $ | 41,351 | |||||||
Short-term investments | 93,526 | 112,281 | |||||||||
Accounts receivable, net | 31,263 | 44,848 | |||||||||
Deferred commissions | 13,187 | 15,421 | |||||||||
Prepaid expenses and other current assets | 10,092 | 10,385 | |||||||||
Total current assets | 210,675 | 224,286 | |||||||||
Property and equipment, net | 7,053 | 5,327 | |||||||||
Operating lease right-of-use assets | 3,497 | 4,848 | |||||||||
Deferred commissions, noncurrent | 13,603 | 11,400 | |||||||||
Other assets | 1,119 | 1,891 | |||||||||
Total assets | $ | 235,947 | $ | 247,752 | |||||||
Liabilities and Stockholders’ Equity | |||||||||||
Current liabilities | |||||||||||
Accounts payable | $ | 5,031 | $ | 4,865 | |||||||
Accrued compensation and benefits | 14,123 | 18,116 | |||||||||
Other accrued expenses | 3,373 | 4,581 | |||||||||
Operating lease liabilities | 2,670 | 3,208 | |||||||||
Deferred revenue | 81,906 | 81,736 | |||||||||
Total current liabilities | 107,103 | 112,506 | |||||||||
Operating lease liabilities, noncurrent | 1,170 | 2,078 | |||||||||
Deferred revenue, noncurrent | 1,031 | 2,747 | |||||||||
Total liabilities | 109,304 | 117,331 | |||||||||
Stockholders’ equity | |||||||||||
Preferred stock | — | — | |||||||||
Common stock | — | — | |||||||||
Additional paid-in capital | 658,165 | 621,024 | |||||||||
Accumulated other comprehensive income | 27 | 56 | |||||||||
Accumulated deficit | (531,549) | (490,659) | |||||||||
Total stockholders’ equity | 126,643 | 130,421 | |||||||||
Total liabilities and stockholders’ equity | $ | 235,947 | $ | 247,752 |
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Cash flows from operating activities | |||||||||||||||||||||||
Net loss | $ | (19,895) | $ | (20,651) | $ | (40,890) | $ | (42,526) | |||||||||||||||
Adjustments to reconcile net loss to net cash used in operating activities | |||||||||||||||||||||||
Depreciation and amortization | 363 | 745 | 763 | 1,635 | |||||||||||||||||||
Stock-based compensation, net of amounts capitalized | 16,156 | 12,117 | 30,783 | 21,393 | |||||||||||||||||||
Amortization of deferred commissions | 4,184 | 4,702 | 8,280 | 9,242 | |||||||||||||||||||
Non-cash lease expense | 765 | 776 | 1,530 | 1,548 | |||||||||||||||||||
Foreign currency transaction losses (gains) | 8 | 249 | 291 | 165 | |||||||||||||||||||
Other | (589) | (1,030) | (1,413) | (1,776) | |||||||||||||||||||
Changes in operating assets and liabilities | |||||||||||||||||||||||
Accounts receivable | 3,130 | 9,811 | 13,295 | 7,537 | |||||||||||||||||||
Deferred commissions | (5,179) | (4,322) | (8,249) | (9,146) | |||||||||||||||||||
Prepaid expenses and other assets | 412 | (1,523) | 443 | (118) | |||||||||||||||||||
Accounts payable | 938 | (3,713) | 146 | 1,745 | |||||||||||||||||||
Accrued compensation and benefits | 5,188 | 2,306 | (3,991) | (1,754) | |||||||||||||||||||
Other Accrued Expenses | (294) | (615) | (1,107) | (1,871) | |||||||||||||||||||
Operating lease liabilities | (782) | (897) | (1,625) | (1,723) | |||||||||||||||||||
Deferred revenue | (9,255) | 1,526 | (1,547) | 7,949 | |||||||||||||||||||
Net cash used in operating activities | (4,850) | (519) | (3,291) | (7,700) | |||||||||||||||||||
Cash flows from investing activities | |||||||||||||||||||||||
Purchases of short-term investments | (18,351) | (56,494) | (37,805) | (64,315) | |||||||||||||||||||
Maturities of short-term investments | 34,000 | 50,697 | 58,144 | 70,120 | |||||||||||||||||||
Additions to property and equipment | (1,067) | (1,071) | (2,062) | (2,359) | |||||||||||||||||||
Net cash provided by (used in) investing activities | 14,582 | (6,868) | 18,277 | 3,446 | |||||||||||||||||||
Cash flows from financing activities | |||||||||||||||||||||||
Proceeds from exercise of stock options | 842 | 2,733 | 4,136 | 4,650 | |||||||||||||||||||
Proceeds from issuance of common stock under ESPP | — | — | 1,795 | 847 | |||||||||||||||||||
Net cash provided by financing activities | 842 | 2,733 | 5,931 | 5,497 | |||||||||||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 58 | (149) | (204) | (252) | |||||||||||||||||||
Net increase in cash, cash equivalents and restricted cash | 10,632 | (4,803) | 20,713 | 991 | |||||||||||||||||||
Cash, cash equivalents, and restricted cash at beginning of period | 51,975 | 46,783 | 41,894 | 40,989 | |||||||||||||||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 62,607 | $ | 41,980 | $ | 62,607 | $ | 41,980 | |||||||||||||||
Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown above: | |||||||||||||||||||||||
Cash and cash equivalents | $ | 62,607 | $ | 41,437 | $ | 62,607 | $ | 41,437 | |||||||||||||||
Restricted cash included in other assets | — | 543 | — | 543 | |||||||||||||||||||
Total cash, cash equivalents and restricted cash | $ | 62,607 | $ | 41,980 | $ | 62,607 | $ | 41,980 |
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Reconciliation of GAAP gross profit to non-GAAP gross profit: | |||||||||||||||||||||||
Total revenue | $ | 51,589 | $ | 43,139 | $ | 102,916 | $ | 84,135 | |||||||||||||||
Gross profit | $ | 45,126 | $ | 37,230 | $ | 90,771 | $ | 72,304 | |||||||||||||||
Add: Stock-based compensation expense | 410 | 385 | 817 | 723 | |||||||||||||||||||
Add: Employer taxes on employee stock transactions | 28 | 21 | 98 | 31 | |||||||||||||||||||
Non-GAAP gross profit | $ | 45,564 | $ | 37,636 | $ | 91,686 | $ | 73,058 | |||||||||||||||
Gross margin | 87.5 | % | 86.3 | % | 88.2 | % | 85.9 | % | |||||||||||||||
Non-GAAP gross margin | 88.3 | % | 87.2 | % | 89.1 | % | 86.8 | % |
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Reconciliation of GAAP operating expenses to non-GAAP operating expenses: | |||||||||||||||||||||||
GAAP research and development | $ | 17,370 | $ | 16,292 | $ | 35,217 | $ | 31,675 | |||||||||||||||
Less: Stock-based compensation expense | (4,214) | (3,614) | (8,207) | (6,382) | |||||||||||||||||||
Less: Employer taxes on employee stock transactions | (170) | (123) | (479) | (231) | |||||||||||||||||||
Non-GAAP research and development | $ | 12,986 | $ | 12,555 | $ | 26,531 | $ | 25,062 | |||||||||||||||
GAAP sales and marketing | $ | 36,168 | $ | 32,348 | $ | 73,923 | $ | 64,901 | |||||||||||||||
Less: Stock-based compensation expense | (6,162) | (4,032) | (11,385) | (7,273) | |||||||||||||||||||
Less: Employer taxes on employee stock transactions | (421) | (330) | (1,103) | (450) | |||||||||||||||||||
Non-GAAP sales and marketing | $ | 29,585 | $ | 27,986 | $ | 61,435 | $ | 57,178 | |||||||||||||||
GAAP general and administrative | $ | 12,636 | $ | 10,459 | $ | 25,219 | $ | 20,084 | |||||||||||||||
Less: Stock-based compensation expense | (5,370) | (4,086) | (10,374) | (7,014) | |||||||||||||||||||
Less: Employer taxes on employee stock transactions | (172) | (59) | (327) | (88) | |||||||||||||||||||
Non-GAAP general and administrative | $ | 7,094 | $ | 6,314 | $ | 14,518 | $ | 12,982 | |||||||||||||||
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Reconciliation of GAAP operating loss to non-GAAP operating loss: | |||||||||||||||||||||||
Total revenue | $ | 51,589 | $ | 43,139 | $ | 102,916 | $ | 84,135 | |||||||||||||||
Loss from operations | $ | (21,048) | $ | (21,869) | $ | (43,588) | $ | (44,402) | |||||||||||||||
Add: Stock-based compensation expense | 16,156 | 12,117 | 30,783 | 21,392 | |||||||||||||||||||
Add: Employer taxes on employee stock transactions | 791 | 533 | 2,007 | 800 | |||||||||||||||||||
Add: Restructuring(2) | — | — | — | 46 | |||||||||||||||||||
Non-GAAP operating loss | $ | (4,101) | $ | (9,219) | $ | (10,798) | $ | (22,164) | |||||||||||||||
Operating margin | (41) | % | (51) | % | (42) | % | (53) | % | |||||||||||||||
Non-GAAP operating margin | (8) | % | (21) | % | (10) | % | (26) | % |
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Reconciliation of GAAP net loss to non-GAAP net loss: | |||||||||||||||||||||||
Net loss | $ | (19,895) | $ | (20,651) | $ | (40,890) | $ | (42,526) | |||||||||||||||
Add: Stock-based compensation expense | 16,156 | 12,117 | 30,783 | 21,392 | |||||||||||||||||||
Add: Employer taxes on employee stock transactions | 791 | 533 | 2,007 | 800 | |||||||||||||||||||
Add: Restructuring(2) | — | — | — | 46 | |||||||||||||||||||
Non-GAAP net loss | $ | (2,948) | $ | (8,001) | $ | (8,100) | $ | (20,288) | |||||||||||||||
GAAP net loss per share | $ | (0.39) | $ | (0.44) | $ | (0.81) | $ | (0.92) | |||||||||||||||
Non-GAAP net loss per share | $ | (0.06) | $ | (0.17) | $ | (0.16) | $ | (0.44) | |||||||||||||||
Weighted average shares outstanding, basic and diluted | 50,822 | 46,714 | 50,311 | 46,285 |
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net cash used in operating activities | $ | (4,850) | $ | (519) | $ | (3,291) | $ | (7,700) | |||||||||||||||
Less: Additions to property and equipment | (1,067) | (1,071) | (2,062) | (2,359) | |||||||||||||||||||
Free cash flow | $ | (5,917) | $ | (1,590) | $ | (5,353) | $ | (10,059) | |||||||||||||||
Net cash provided by (used in) investing activities | $ | 14,582 | $ | (6,868) | $ | 18,277 | $ | 3,446 | |||||||||||||||
Net cash provided by financing activities | $ | 842 | $ | 2,733 | $ | 5,931 | $ | 5,497 |
As of | ||||||||||||||||||||||||||||||||||||||||||||||||||
Oct. 31, | Jan. 31, | April 30, | July 31, | Oct. 31, | Jan. 31, | April 30, | July 31, | |||||||||||||||||||||||||||||||||||||||||||
2022 | 2023 | 2023 | 2023 | 2023 | 2024 | 2024 | 2024 | |||||||||||||||||||||||||||||||||||||||||||
Annual Recurring Revenue | $ | 151.7 | $ | 163.7 | $ | 172.2 | $ | 180.7 | $ | 188.7 | $ | 204.2 | $ | 207.7 | $ | 214.0 |
GJ&N9(Q[6O8]CAAS'L<"
MU[' D.:X%K@2""%:-Z5?5_D+'*5C;3NPL .9>14:P>,LSRRY2+2;TPD0C:CD
M1T8"E,_4X*FRESB KJ"5!]^$,1P:?]O=RGSO@L6HY^J1^&4]4XXZCX-BG/AD
M^#9#XG#7\D%::>VIV$*2TT=WW>V0M? 1$I!4H#P8=$7>G>^?S^["_V/9I_CRGZ(HA.W?Z.F,.KAGK+\3FW)
M-KI6*< 5>FVFQUVAH,D+=?W=QFI2-C85I9)-)9"KQ22<(^.[<%:N7*GK))-R
MI")UR$4VW7"[6G;AM>V$A6X+<#R(
ME]0H" <J]4O>9DW;)9<+Q&W]B\I(V[;HF\MSBU6J\+UA116^UZU/_ ()J
MR)8"PB[:28-V" $!K%2!5%5CIIF$BDDZRNS9YN?VV#
Cover |
Sep. 04, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Sep. 04, 2024 |
Entity Registrant Name | Couchbase, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-40601 |
Entity Tax Identification Number | 26-3576987 |
Entity Address, Address Line One | 3250 Olcott Street |
Entity Address, City or Town | Santa Clara |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 95054 |
City Area Code | 650 |
Local Phone Number | 417-7500 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, $0.00001 par value per share |
Trading Symbol | BASE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Central Index Key | 0001845022 |
Amendment Flag | false |
Entity Ex Transition Period | false |
-8?20$3;8T.P6BP^0"X9
M9K>]9!:G
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